Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

We know IPCI's developed their own proprietary delivery tech just as COLL did with Remoxy...so IMO their now assembled legal team are going to easily crush the frivolous Purdue lawsuit and it's only a matter of time now until a big Rexista deal gets announced and a big fund starts accumulating.

To say IPCI's 1 of the most under-valued and battered bio's out there right now is putting it lightly and we're finally nearing the point where/when a large fund meets with IPCI mgmt. and does a deep vetting dive on just how much potential exists in Dr Odidi's growth pipeline.

We know that Tekla, Sabby & Broadfin all held 2m share positions each approximately 3 years ago until the FDA yanked tentative approval on the additional FocalinXR strengths that are just now being rolled out...which along with Mallinkrodt's roll out of SeroquelXR means there's no longer any lingering doubts/questions as to IPCI's generics pipeline.

So the focus is soon going to shift onto IPCI's much bigger Rexista, PODRAS and Regabatin catalysts...we just don't know exactly when...but guaranteed it's going to occur sometime between now and the Rexista September 28th PDUFA date...and it's only going to take 1 big fund to take an interest here to get the party started